Your browser doesn't support javascript.
loading
Development of clinical prediction rule for the requirement of endoscopic papillary large balloon dilation (EPLBD) on endoscopic CBD stone clearance.
Wongkanong, Chote; Patumanond, Jayanton; Ratanachu-Ek, Thawee; Junrungsee, Sunhawit; Tantraworasin, Apichat.
Afiliação
  • Wongkanong C; Department of Surgery, Pattani Hospital, Pattani, Thailand.
  • Patumanond J; Center for Clinical Epidemiology & Clinical Statistics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Ratanachu-Ek T; Surgical Endoscopy Unit, Department of Surgery Rajavithi Hospital, Department of Medical Services, Ministry of Public Health, Mueang Nonthaburi, Thailand.
  • Junrungsee S; Clinical Surgical Research Center, Chiang Mai University, Chiang Mai, Thailand.
  • Tantraworasin A; Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
PLoS One ; 18(3): e0282899, 2023.
Article em En | MEDLINE | ID: mdl-36928213
ABSTRACT

INTRODUCTION:

To develop a simplified scoring system for clinical prediction of difficulty in CBD stone removal to assist endoscopists working in resource-limited settings in deciding whether to proceed with an intervention or refer patients to a center capable of performing additional procedures and interventions.

METHODS:

This study included patients with CBD stones who underwent ERCP at Pattani Hospital between August 2017 and December 2021. Retrospective cohort data was collected and patients were categorized into two groups bile duct stones successfully treated by endoscopic biliary sphincterotomy and extraction compared to the former method combined with EPLBD. We explored potential predictors using multivariable logistic regression. The chosen logistic coefficients were transformed into a scoring system based on risk with internal validation via bootstrapping procedure.

RESULTS:

Among the 155 patients who had successful endoscopic therapy for bile duct stones, there were 79 (50.97%) cases of endoscopic biliary sphincterotomy, EPLBD and extraction versus 76 (49.03%) cases without EPLBD. The factors used to derive a scoring system included the size of CBD stones >15 mm, the difference between the stone and distal CBD diameter >2mm, distal CBD arm length <36 mm and stone shape. The score-based model's area under ROC was 0.88 (95% CI 0.83, 0.93). For clinical use, the range of scores from 0 to 16, was divided into two subcategories based on CBD stone removal difficulty requiring EPLBD to derive the PPV. For scores <5 and ≥ 5, the PPV was 23.40 (p <0.001) and 93.44 (p <0.001) respectively. The Bootstrap sampling method indicated a prediction ability of 0.88 (AuROC, 95% CI 0.83, 0.94).

CONCLUSION:

This scoring system has acceptable prediction performance in assisting endoscopists in their choice of stone removal procedure.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colangiopancreatografia Retrógrada Endoscópica / Coledocolitíase Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colangiopancreatografia Retrógrada Endoscópica / Coledocolitíase Idioma: En Ano de publicação: 2023 Tipo de documento: Article